Abstract
Background: Type 2 diabetes (adult onset diabetes) is the most common type of diabetes, accounting for around 90% of all diabetes cases with insulin resistance and insulin secretion defect. The key goal of anti-diabetic therapy is to increase the development of insulin, immunity and/or decrease the amount of blood glucose. While many synthetic compounds have been produced as antidiabetic agents, due to their side effects and limited effectiveness, their usefulness has been hindered.
Methods: This systematic review investigated the bioactive compounds reported to possess activities against type 2 diabetes. Three (3) databases, PubMed, ScienceDirect and Google Scholar were searched for research articles published between January 2010 and October 2020. A total of 6464 articles were identified out of which 84 articles were identified to be elligible for the study.
Result and Discussion: From the data extracted, it was found that quercetin, Kaempferol, Rosmarinic acid, Cyanidin, Rutin, Catechin, Luteolin and Ellagic acid were the most cited bioactive compounds which all falls within the class of polyphenolic compounds. The major sources of these bioactive compounds includes citrus fruits, grapes, onions, berries, cherries, broccoli, honey, apples, green tea, Ginkgo biloba, St. John's wort, green beans, cucumber, spinach, tea, Rosmarinus officinalis, Aloe vera, Moringa oleifera, tomatoes, potatoes, oregano, lemon balm, thyme, peppermint, Ocimum basilicum, red cabbage, pears, olive oil and walnut.
Keywords: Type 2 diabetes, (T2DM), Anti-diabetic agents, Bioactive compounds, Phytochemicals, Medicinal plants, Polyphenols, Flavonoids.
Current Topics in Medicinal Chemistry
Title:Bioactive Compounds Effective Against Type 2 Diabetes Mellitus: A Systematic Review
Volume: 21 Issue: 12
Author(s): Chukwuebuka Egbuna*, Chinaza G. Awuchi, Garima Kushwaha, Mithun Rudrapal, Kingsley C. Patrick-Iwuanyanwu, Omkar Singh, Uchenna E. Odoh, Johra Khan, Jaison Jeevanandam, Suresh Kumarasamy, Vincent O. Chukwube, Mathiyazhagan Narayanan, Santwana Palai, Mihnea-Alexandru Găman, Chukwuemelie Z. Uche, Daprim S. Ogaji, Nebechi J. Ezeofor, Andrew G. Mtewa, Chinyere C. Patrick-Iwuanyanwu, Shyam S. Kesh, Chandan Shivamallu, Kaliyaperumal Saravanan, Habibu Tijjani, Muhammad Akram, Jonathan C. Ifemeje, Michael C. Olisah and Chukwudi J. Chikwendu
Affiliation:
- World Bank Africa Centre of Excellence in Public Health and Toxicological Research (PUTOR), University of Port-Harcourt, Rivers State,Nigeria
Keywords: Type 2 diabetes, (T2DM), Anti-diabetic agents, Bioactive compounds, Phytochemicals, Medicinal plants, Polyphenols, Flavonoids.
Abstract:
Background: Type 2 diabetes (adult onset diabetes) is the most common type of diabetes, accounting for around 90% of all diabetes cases with insulin resistance and insulin secretion defect. The key goal of anti-diabetic therapy is to increase the development of insulin, immunity and/or decrease the amount of blood glucose. While many synthetic compounds have been produced as antidiabetic agents, due to their side effects and limited effectiveness, their usefulness has been hindered.
Methods: This systematic review investigated the bioactive compounds reported to possess activities against type 2 diabetes. Three (3) databases, PubMed, ScienceDirect and Google Scholar were searched for research articles published between January 2010 and October 2020. A total of 6464 articles were identified out of which 84 articles were identified to be elligible for the study.
Result and Discussion: From the data extracted, it was found that quercetin, Kaempferol, Rosmarinic acid, Cyanidin, Rutin, Catechin, Luteolin and Ellagic acid were the most cited bioactive compounds which all falls within the class of polyphenolic compounds. The major sources of these bioactive compounds includes citrus fruits, grapes, onions, berries, cherries, broccoli, honey, apples, green tea, Ginkgo biloba, St. John's wort, green beans, cucumber, spinach, tea, Rosmarinus officinalis, Aloe vera, Moringa oleifera, tomatoes, potatoes, oregano, lemon balm, thyme, peppermint, Ocimum basilicum, red cabbage, pears, olive oil and walnut.
Export Options
About this article
Cite this article as:
Egbuna Chukwuebuka*, Awuchi G. Chinaza, Kushwaha Garima, Rudrapal Mithun, Patrick-Iwuanyanwu C. Kingsley, Singh Omkar, Odoh E. Uchenna, Khan Johra, Jeevanandam Jaison, Kumarasamy Suresh, Chukwube O. Vincent, Narayanan Mathiyazhagan, Palai Santwana, Găman Mihnea-Alexandru, Uche Z. Chukwuemelie, Ogaji S. Daprim, Ezeofor J. Nebechi, Mtewa G. Andrew, Patrick-Iwuanyanwu C. Chinyere, Kesh S. Shyam, Shivamallu Chandan, Saravanan Kaliyaperumal, Tijjani Habibu, Akram Muhammad, Ifemeje C. Jonathan, Olisah C. Michael and Chikwendu J. Chukwudi, Bioactive Compounds Effective Against Type 2 Diabetes Mellitus: A Systematic Review, Current Topics in Medicinal Chemistry 2021; 21 (12) . https://dx.doi.org/10.2174/1568026621666210509161059
DOI https://dx.doi.org/10.2174/1568026621666210509161059 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
Drug Discovery in the Age of Artificial Intelligence
In the age of artificial intelligence (AI), we have witnessed a significant boom in AI techniques for drug discovery. AI techniques are increasingly integrated and accelerating the drug discovery process. These developments have not only attracted the attention of academia and industry but also raised important questions regarding the selection ...read more
From Biodiversity to Chemical Diversity: Focus of Flavonoids
Flavonoids are the largest group of polyphenols, plant secondary metabolites arising from the essential aromatic amino acid phenylalanine (or more rarely from tyrosine) via the phenylpropanoid pathway. The flavan nucleus is the basic 15-carbon skeleton of flavonoids (C6-C3-C6), which consists of two phenyl rings (A and B) and a heterocyclic ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pharmacogenetics of Antihypertensive Therapies: Can this be Applied in the Clinic?
Current Pharmacogenomics and Personalized Medicine Q Fever Endocarditis
Infectious Disorders - Drug Targets The Adult Patient with Eisenmenger Syndrome: A Medical Update after Dana Point Part III: Specific Management and Surgical Aspects
Current Cardiology Reviews Role of Hexokinase and VDAC in Neurological Disorders
Current Molecular Pharmacology Vasculogenic and Angiogenic Pathways in Moyamoya Disease
Current Medicinal Chemistry Use of Medication in Coronary Imaging by CT
Current Medical Imaging The Role of Transforming Growth Factor β1 in the Regulation of Blood Pressure
Current Hypertension Reviews Recent Progress Toward Hydrogen Medicine: Potential of Molecular Hydrogen for Preventive and Therapeutic Applications
Current Pharmaceutical Design The Genetics of Small-Vessel Disease
Current Medicinal Chemistry Pharmacotherapy for Obesity
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Enteric Nervous System in Neonatal Necrotizing Enterocolitis
Current Pediatric Reviews Current Pharmacologic Management of Pediatric Heart Failure in Congenital Heart Disease
Current Vascular Pharmacology Group I Metabotropic Glutamate Receptor Signalling and its Implication in Neurological Disease
CNS & Neurological Disorders - Drug Targets Current Outcomes and Considerations in Hypoplastic Left Heart Syndrome
Current Pediatric Reviews Current Management of Vascular Tumors in the Neonate
Current Pediatric Reviews Cellular Therapy of Lysosomal Storage Disorders: Current Status and Future Prospects
Current Pediatric Reviews Molecular Cytogenetics and Cytogenomics of Brain Diseases
Current Genomics Cell-based Treatment of Cerebral Palsy: Still a Long Way Ahead
Current Stem Cell Research & Therapy Pathophysiology of Post-Operative Low Cardiac Output Syndrome
Current Vascular Pharmacology Colchicine, Biologic Agents and More for the Treatment of Familial Mediterranean Fever. The Old, the New, and the Rare
Current Medicinal Chemistry